Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous Study

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

May 29, 2019

Primary Completion Date

September 30, 2027

Study Completion Date

April 27, 2028

Conditions
Generalized Pustular Psoriasis
Interventions
DRUG

Spesolimab

Solution for infusion

DRUG

Spesolimab

Solution for injection

Trial Locations (57)

333

Chang Gung Medical Foundation (CGMF) - Linkou Bran, Linkou District

1007

La Rabta Hospital, Tunis

1053

Hedi Chaker Hospital, Department of Dermatology, Tunisia

1200

Cliniques Universitaires Saint-Luc, Brussels

1229

Center for Skin Research, Testing and Product Development, Makati City

4000

Farhat Hached Hospital, Sousse

5000

Iloilo Doctors Hospital, Iloilo City, Iloilo

8000

Southern Philippines Medical Center -Davao-62091, Davao City

10000

National Hospital of Dermatology and Venereology, Hà Nội

10002

National Taiwan University Hospital, Taipei

10029

Icahn School of Medicine at Mount Sinai, New York

10117

Charite Universitätsmedizin Berlin KöR, Berlin

10400

Institute of Dermatology, Bangkok

Ramathibodi Hospital, Bangkok

10990

Hospital Pulau Pinang-Pulau Pinang-21953, George Town

20089

Istituto Clinico Humanitas, Rozzano (MI)

26133

Klinikum Oldenburg AöR, Oldenburg

30450

Hospital Raja Permaisuri Bainun, Ipoh

33000

HOP Saint-André, Bordeaux

34890

Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi, Istanbul

48149

Westfälische Wilhelms-Universität Münster, Münster

48326

Oakland Hills Dermatology, Auburn Hills

48455

Fachklinik Bad Bentheim, Bad Bentheim

50586

Hospital Kuala Lumpur, Kuala Lumpur

51092

HOP Robert Debré, Reims

53127

Universitätsklinikum Bonn AöR, Bonn

60596

Universitätsklinikum Frankfurt, Frankfurt am Main

64460

Hospital Universitario Dr Jose Eleuterio Gonzalez, Monterrey

68100

Hospital Selayang, Kuala Selangor

70000

HCMC Hospital of Dermato-Venereology-Ho Chi Minh-66092, Ho Chi Minh City

75010

HOP Saint-Louis, Paris

80100

Hospital Sultanah Aminah, Johor Bahru

80337

Klinikum der Universität München - Campus Innenstadt, München

81100

Hospital Sultan Ismail, Johor Bahru

84000

Hospital Pakar Sultanah Fatimah, Muar town

88586

Queen Elizabeth Hospital-Kota Kinabalu-40735, Kota Kinabalu

93586

Sarawak General Hospital, Kuching, Sarawak

169608

Singapore General Hospital, Singapore

190123

LLC Skin Disease Clinic of Pier Volkenstein, St. Petersburg, Saint Petersburg

200000

Shanghai Skin Disease Hospital, Shanghai

200040

Huashan Hospital, Fudan University, Shanghai

310009

The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

410028

Saratov State Med.Univ.n.a.Razumovskogo, Saratov

420111

"LLC Medical Center Azbuka Zdorovia", Kazan'

454048

SBHI Chelyabinsk Reg.Clin.Derma.Dispen., Chelyabinsk

510288

Sun yet-sen Memorial Hospital, Sun yet-sen Univesity, Guangzhou

610035

"FSBEI HE Kirov State Medical University", Kirov

710004

Second Affiliated Hospital of Xi'an JiaoTong University, Xi'an

7640881

Clínica Dermacross S.A., Vitacura

C1199ABD

Hospital Italiano de Buenos Aires, CABA

06200

HOP l'Archet, Nice

467-8602

Nagoya City University Hospital, Aichi, Nagoya

300-0395

Tokyo Medical University Ibaraki Medical Center, Ibaraki, Inashiki-gun

350-0495

Saitama Medical University Hospital, Saitama, Iruma-gun

193-0998

Tokyo Medical University Hachioji Medical Center, Tokyo, Hachioji

03722

Severance Hospital, Seoul

08950

Hospital Sant Joan de Déu, Esplugues Del Llobregat

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY